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Abstract: 
The software tool PBEAM provides a parallel implementation of the BEAM, which is the first algorithm for large scale 
epistatic interaction mapping, including genome-wide studies with hundreds of thousands of markers. BEAM describes 
markers and their interactions with a Bayesian partitioning model and computes the posterior probability of each marker sets 
via Markov Chain Monte Carlo (MCMC). PBEAM takes the advantage of simulating multiple Markov chains 
simultaneously. This design can efficiently reduce ~n-fold execution time in the circumstance of n CPUs. The 
implementation of PBEAM is based on MPI libraries.  
 
Availability: PBEAM is available for download at http://bioinfo.au.tsinghua.edu.cn/pbeam/. 
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Background: 
Many genes that are responsible for Mendelian diseases 
have been successfully mapped during recent decades. In 
recent years, the number of polymorphisms considered in 
genetic association study has increased dramatically as the 
high-throughput genotyping technologies develop rapidly. 
This increase offers a unique chance to identify genes for 
complex traits through an unbiased search at a genome-
wide level [1]. Recent studies have revealed more than 50 
novel susceptible loci for many complex diseases [2], 
including obesity, age-related macular degeneration and 
heart disease. However, genetic polymorphisms underlying 
most common disease are epistatic: these variations 
interact with each other and interact with environment 
factors in a complex way. Detecting and characterizing 
these interactions is crucial for our understanding of these 
common and complex diseases. Several approaches to 
detect epitasis have been developed (e.g. MDR [3], MPVA 
[4], BGTA [5]). These approaches all showed promise on 
small data sets, but they are quickly overwhelmed by the 
genome-scale data. A Monte Carlo simulation based 
approach, called BEAM (Bayesian Epitasis Association 
Mapping), which was recently introduced by Zhang and 
Liu (2007), can infer possible epistatic interactions among 
a large number of polymorphisms. In this paper, we 
present PBEAM (Parallel BEAM), which is an improved 
and parallelized version of BEAM, to facilitate the 
genome-wide epistasis mapping.  
 
Methodology: 
Genome-wide scale epistatic interaction inference: 
BEAM [6] proposed a Bayesian partition model to describe 
the disease-associated markers and their interactions. For a 
population-based association study, all the markers across 
the whole genome are partitioned into three groups: group 
0 contains markers unrelated to the disease, group 1 
contains markers contributing independently to the disease 
risk and group 2 contains markers that jointly affecting the 
disease risk. Thus, the association study problem is 
transformed into inferring the composition of disease sets, 
that is, which markers belongs to group 1 and group 2.  
Given the genotype in the case and control populations, the 
likelihood of a possible partition I (the assignment of each 
marker to group 0, 1 and 2) can be theoretically calculated. 
With the likelihood function, the posterior probability that 
each marker set is associated with the disease can be 
estimated with Markov Chain Monte Carlo (MCMC) 
simulation. 
 
The goal of the MCMC procedure is to draw the partition I 
from the distribution conditioned on observed case and 
control data. Partition I was initialized according to a 
simple theoretical prior. Metropolis-Hastings (MH) 
algorithm was then used to update the partition I. The 
authors used two types of update proposals: (1) randomly 
switch a marker’s group membership (e.g. from 0 to 1 or 
from 1 to 2); (2) randomly exchange two markers between 
different groups. As a standard step in MH algorithm, the 
proposed update is accepted according to the likelihood 
ratio. BEAM algorithm also takes some annealing-like 
techniques to improve the sampling performance. The 
many samples of I drawn by MCMC can finally serve as 
Bayesian-style estimation or the potential ‘hits’ (the most 
probable partitions). The likelihood-based simulation 
avoids the computationally infeasible enumeration of all 
the possible combinations of makers, but is still 
computationally intensive. The execution time of drawing 
millions of samples from a MCMC chain, which is 
necessary for a stable estimation, has hampered some of 
the further studies, like permutation analysis. 
 
Parallelization of the Bayesian algorithm: 
To reduce the execution time of BEAM, we developed a 
parallel version, called PBEAM. The design of PBEAM 
takes the advantage that samples can be drew from several 
Markov chains simulated simultaneously on different 
computers. We analyzed the source code of BEAM and 
adapted the algorithm framework and data structure of 
BEAM to the distributed memory parallelism. In the 
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distributed to different processes using MPI, which can be  executed on various heterogeneous platforms. 
 
 
Figure 1: Parallelization scheme of PBEAM. 
 
 
Figure 2: Average execution time for 106 iterations on dat sets of 1000 loci, 400 cases and 400 controls 
 
 
We have optimized and parallelized the PBEAM program 
with master/slave architecture. The Master process 
schedules and distributes blocks of chains to the slave 
process, which actually perform the tasks (Fig. 1). After 
sampling, the master collects all the samples from slaves 
and adaptively schedules the calculation of B-statistics [6] 
on all the combination of possible disease-associated 
markers. Final reports are based on the results across all 
process. 
 
Utility: 
There is a wide spectrum of epistatic interaction models for 
disease-associated markers. We chose three common two-
loci models (additive, multiplicative and multiplicative 
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400 cases and 400 controls) for each model. Each data set 
was performed on 1 (BEAM) and multiple (PBEAM) 
processors of an AMD 2GHz Opteron cluster. The 
execution time of 10 independent repetitions for each 
number of CPUs are averaged for comparison. This 
experiment design reflects two concerns: 1) the speedup 
performance of PBEAM; 2) the results consistence of 
BEAM and PBEAM, considering result variance is 
intrinsic for stochastic sampling algorithms.   
 
The parallel program PBEAM presents an almost perfect 
speedup. The communication cost between processes and 
the initial tries of each Markov chain lead to only a slight 
performance loss (Fig 2). The result variance of PBEAM 
and BEAM are in comparable range. This performance 
improvement is crucial for large dataset of the state-of-the-
art genome wide association studies. A typical dataset[8] 
of these researches consists of ~4000 individuals (e.g. 2000 
cases and 2000 controls) and each individual is genotyped 
at ~ 500K markers. For a dataset of this size, BEAM took 
27.5 days to draw 10
9 samples from one Markov chain. 
With 16 processors, PBEAM could finish the inference 
procedure within 2 days. 
  
Caveat and future development: 
The detailed information about the usage of PBEAM 
source code and executables could be found in the readme 
and website. Currently, PBEAM chains treat the MCMC 
local mode issues independently. Future development 
could include determining the burn-in time and merging 
the samples collectively between chains. 
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